Description
Resistant hypertension is estimated to affect ~25% of hypertensive patients on treatment. Screening for a secondary cause such as primary aldosteronism is strongly indicated. However, are patients actually being screened in primary care? If we systematically test for primary aldosteronism in this population, what proportion will be found to have the condition? We will work with research-focussed primary care clinics and general practitioners to co-design a strategy to screen these patients for a potentially curable cause of hypertension.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
primary aldosteronism, hypertension, endocrine hypertension, resistant hypertension, primary care
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options
PhD/Doctorate
BMedSc(Hons)
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Monash Health Translation Precinct (Monash Medical Centre)
Co-supervisors
Prof
Grant Russell